These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9931877)

  • 21. Clinical results on intra-arterial adjuvant chemotherapy for prevention of liver metastasis following curative resection of pancreatic cancer.
    Hayashibe A; Kameyama M; Shinbo M; Makimoto S
    Ann Surg Oncol; 2007 Jan; 14(1):190-4. PubMed ID: 17066232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unresectable pancreatic cancer: is a multi-modality approach a promising therapeutical alternative?
    Lygidakis NJ; Dedemati G; Spenzaris N; Theodoropoulou M
    Hepatogastroenterology; 1997; 44(16):1222-8. PubMed ID: 9261631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure.
    Ducreux M; Boige V; Goéré D; Deutsch E; Ezra P; Elias D; Malka D
    Best Pract Res Clin Gastroenterol; 2007; 21(6):997-1014. PubMed ID: 18070700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer.
    Ghaneh P; Neoptolemos JP
    Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of systemic therapy for advanced pancreatic cancer.
    El-Rayes BF; Philip PA
    Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Isolated hypoxic perfusion with mitomycin C confers no benefit for patients with advanced pancreatic carcinoma].
    Petrowsky H; Heinrich S; Staib-Sebler E; Gog C; Janshon G; Lorenz M
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1351-3. PubMed ID: 9931879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regional celiac artery infusion in the adjuvant treatment of pancreatic cancer.
    Papachristou E; Link KH; Schoenberg MH
    Anticancer Res; 2003; 23(2A):831-4. PubMed ID: 12820308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of non-resectable pancreatic cancer with intraperitoneal 5-FU and leucovorin IV.
    Oman M; Blind PJ; Naredi P; Gustavsson B; Hafström LO
    Eur J Surg Oncol; 2001 Aug; 27(5):477-81. PubMed ID: 11504519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxic abdominal stop-flow perfusion in the treatment of advanced pancreatic cancer: a phase II evaluation/trial.
    Guadagni S; Clementi M; Valenti M; Fiorentini G; Cantore M; Kanavos E; Caterino GP; Di Giuro G; Amicucci G
    Eur J Surg Oncol; 2007 Feb; 33(1):72-8. PubMed ID: 17166688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonging survival in inoperable pancreatic cancer with combination chemotherapy.
    Goel AK; Seenu V
    Trop Gastroenterol; 1995; 16(2):141-3. PubMed ID: 8644365
    [No Abstract]   [Full Text] [Related]  

  • 32. Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas.
    Kouvaraki MA; Ajani JA; Hoff P; Wolff R; Evans DB; Lozano R; Yao JC
    J Clin Oncol; 2004 Dec; 22(23):4762-71. PubMed ID: 15570077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer.
    Kosuge T; Kiuchi T; Mukai K; Kakizoe T;
    Jpn J Clin Oncol; 2006 Mar; 36(3):159-65. PubMed ID: 16490736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential polychemotherapy in exocrine pancreatic cancer.
    Klapdor R; Bahlo M; Babinski A; Broemel T; Müller C; Seutter R
    Anticancer Res; 2003; 23(2A):841-4. PubMed ID: 12820310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of adjuvant therapy on survival of patients with pancreatic carcinoma of body and tail: a report of 137 cases].
    Xie YB; Wang CF; Li CR; Shan Y; Zhao DB; Tian YT; Zhao P
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(14):951-4. PubMed ID: 19671304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
    Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
    Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant therapy for pancreatic cancer: an evolving paradigm.
    Zhu AX; Clark JW; Willett CG
    Surg Oncol Clin N Am; 2004 Oct; 13(4):605-20, viii. PubMed ID: 15350937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer.
    Huguier M; Barrier A; Valinas R; Flahault A; Adloff M; Pezet D; Jaeck D; Millat B;
    Hepatogastroenterology; 2001; 48(39):875-8. PubMed ID: 11462946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined regional and systemic chemotherapy for advanced and inoperable non-small cell lung cancer.
    Müller H
    Eur J Surg Oncol; 2002 Mar; 28(2):165-71. PubMed ID: 11884052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.